Yubo International Biotech Limited (YBGJ)

Market Cap	903.23K -60.4%
Revenue (ttm)	12.35K +256.0%
Net Income	-1.06M
EPS	-0.01
Shares Out	170.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,876
Open	0.0053
Previous Close	0.0053
Day's Range	0.0053 - 0.0053
52-Week Range	0.0049 - 0.0151
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound dr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2025, YBGJ's revenue was $12,353, an increase of 255.99% compared to the previous year's $3,470. Losses were -$1.08 million, -39.21% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error